Alnylam Pharmaceuticals, Inc. (ALNY)
156.65
-3.20
(-2.00%)
USD |
NASDAQ |
Nov 12, 16:00
157.66
+1.01
(+0.64%)
After-Hours: 07:24
Alnylam Pharmaceuticals Total Liabilities (Quarterly) : 4.391B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.391B |
| June 30, 2026 | 4.205B |
| March 31, 2026 | 4.054B |
| December 31, 2025 | 4.236B |
| September 30, 2025 | 4.618B |
| June 30, 2025 | 4.315B |
| March 31, 2025 | 4.098B |
| December 31, 2024 | 4.235B |
| September 30, 2024 | 4.173B |
| June 30, 2024 | 4.013B |
| March 31, 2024 | 4.044B |
| December 31, 2023 | 4.051B |
| September 30, 2023 | 4.005B |
| June 30, 2023 | 3.811B |
| March 31, 2023 | 3.651B |
| December 31, 2022 | 3.705B |
| September 30, 2022 | 3.603B |
| June 30, 2022 | 3.154B |
| March 31, 2022 | 3.032B |
| December 31, 2021 | 3.055B |
| September 30, 2021 | 2.716B |
| June 30, 2021 | 2.656B |
| March 31, 2021 | 2.329B |
| December 31, 2020 | 2.391B |
| September 30, 2020 | 2.092B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.975B |
| March 31, 2020 | 929.90M |
| December 31, 2019 | 956.44M |
| September 30, 2019 | 934.54M |
| June 30, 2019 | 959.22M |
| March 31, 2019 | 467.01M |
| December 31, 2018 | 272.84M |
| September 30, 2018 | 197.54M |
| June 30, 2018 | 168.59M |
| March 31, 2018 | 168.33M |
| December 31, 2017 | 228.30M |
| September 30, 2017 | 299.45M |
| June 30, 2017 | 311.32M |
| March 31, 2017 | 303.02M |
| December 31, 2016 | 342.59M |
| September 30, 2016 | 297.94M |
| June 30, 2016 | 283.68M |
| March 31, 2016 | 127.90M |
| December 31, 2015 | 121.80M |
| September 30, 2015 | 114.54M |
| June 30, 2015 | 122.17M |
| March 31, 2015 | 132.28M |
| December 31, 2014 | 143.33M |
| September 30, 2014 | 81.88M |
| June 30, 2014 | 90.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.519B |
| Vertex Pharmaceuticals, Inc. | 11.83B |
| Pfizer Inc. | 115.24B |
| BridgeBio Pharma, Inc. | 3.815B |
| Cerenome, Inc. | 8.567M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.995B |
| Shareholders Equity (Quarterly) | 3.604B |
| Debt to Equity Ratio | 0.8316 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | -0.16% |